Skip to Content

Clocortolone Topical Dosage

Applies to the following strength(s): 0.1%

The information at Drugs.com is not a substitute for medical advice. ALWAYS consult your doctor or pharmacist.

Usual Adult Dose for:

Usual Pediatric Dose for:

Additional dosage information:

Usual Adult Dose for Dermatitis

Apply sparingly to the affected areas three times a day and rub in gently

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and anti-microbial therapy initiated.

Use:
-Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Adult Dose for Eczema

Apply sparingly to the affected areas three times a day and rub in gently

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and anti-microbial therapy initiated.

Use:
-Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Dermatitis

Apply sparingly to the affected areas three times a day and rub in gently

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and anti-microbial therapy initiated.

Use:
-Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Usual Pediatric Dose for Eczema

Apply sparingly to the affected areas three times a day and rub in gently

Comments:
-Occlusive dressings may be used; however, if an infection develops, the use of occlusive dressings should be discontinued and anti-microbial therapy initiated.

Use:
-Relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

Pediatric: Children may absorb proportionally larger amounts after topical application and may be more prone to systemic effects. HPA axis suppression, intracranial hypertension, and Cushing's syndrome have been reported in children receiving topical corticosteroids. Prolonged use may affect growth velocity; growth should be routinely monitored in pediatric patients.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:
-Contact with the eyes should be avoided.
-The treated area should not be bandaged, covered, or wrapped, as to be occlusive, unless directed by a healthcare provider.
-Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area.

Storage requirements:
-Store at room temperature; do not freeze.

Monitoring:
-Endocrine: HPA-axis suppression (Urinary free-cortisol test, ACTH-stimulation test)

Patient advice:
-Patients should report any signs of local adverse reactions, especially those that develop under occlusive dressings.

Hide